In vivo droplet vaporization for occlusion therapy and phase aberration correction

The objective was to determine whether a transpulmonary droplet emulsion (90%, <6 μm diameter) could be used to form large gas bubbles (>30 μm) temporarily in vivo. Such bubbles could occlude a targeted capillary bed when used in a large number density. Alternatively, for a very sparse populat...

Full description

Saved in:
Bibliographic Details
Published inIEEE transactions on ultrasonics, ferroelectrics, and frequency control Vol. 49; no. 6; pp. 726 - 738
Main Authors Kripfgans, O.D., Fowlkes, J.B., Woydt, M., Eldevik, O.P., Carson, P.L.
Format Journal Article
LanguageEnglish
Published New York, NY IEEE 01.06.2002
Institute of Electrical and Electronics Engineers
The Institute of Electrical and Electronics Engineers, Inc. (IEEE)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The objective was to determine whether a transpulmonary droplet emulsion (90%, <6 μm diameter) could be used to form large gas bubbles (>30 μm) temporarily in vivo. Such bubbles could occlude a targeted capillary bed when used in a large number density. Alternatively, for a very sparse population of droplets, the resulting gas bubbles could serve as point beacons for phase aberration corrections in ultrasonic imaging. Gas bubbles can be made in vivo by acoustic droplet vaporization (ADV) of injected, superheated, dodecafluoropentane droplets. Droplets vaporize in an acoustic field whose peak rarefactional pressure exceeds a well-defined threshold. In this new work, it has been found that intraarterial and intravenous injections can be used to introduce the emulsion into the blood stream for subsequent ADV (Band M-mode on a clinical scanner) in situ. Intravenous administration results in a lower gas bubble yield, possibly because of filtering in the lung, dilution in the blood volume, or other circulatory effects. Results show that for occlusion purposes, a reduction in regional blood flow of 34% can be achieved. Individual point beacons with a +24 dB backscatter amplitude relative to white matter were created by intravenous injection and ADV.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0885-3010
1525-8955
DOI:10.1109/TUFFC.2002.1009331